Reports for ABBVIE CORPORATION
Company Name
ABBVIE CORPORATION
Totals |
||
Shortage reports |
110 |
|
Actual shortage: | 2 (2%) | |
Anticipated shortage: | 0 (0%) | |
Avoided shortage: | 5 (5%) | |
Resolved: | 103 (94%) | |
Discontinuation Reports |
9 |
|
To be discontinued: | 0 (0%) | |
Discontinued: | 8 (89%) | |
Reversed: | 1 (11%) | |
Late reports |
3 (3%) |
|
Overdue reports |
2 (100%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
OCUFLOX | 0.3% | SOLUTION | Actual shortage | 2024-01-29 | 2024-03-25 | 217532 |
VIIBRYD | 20MG | TABLET | Resolved | 2023-12-07 | 2023-12-08 | 212769 |
VIIBRYD | 10MG | TABLET | Resolved | 2023-12-07 | 2024-01-16 | 212766 |
ZYMAR | 0.3% | SOLUTION | Resolved | 2023-11-14 | 2023-12-07 | 210159 |
SURVANTA | 25MG | SUSPENSION | Avoided shortage | 2023-10-12 | 2023-12-01 | 206918 |
SURVANTA | 25MG | SUSPENSION | Avoided shortage | 2023-10-12 | 2023-12-01 | 206915 |
BYSTOLIC | 2.5MG | TABLET | Resolved | 2023-10-11 | 2023-11-23 | 206797 |
VIIBRYD | 20MG | TABLET | Resolved | 2023-09-11 | 2023-09-29 | 204062 |
CONSTELLA | 290MCG | CAPSULE | Resolved | 2023-09-08 | 2023-09-22 | 203963 |
ALPHAGAN P | 0.15% | SOLUTION | Resolved | 2023-08-14 | 2023-11-28 | 201805 |
ALPHAGAN P | 0.15% | SOLUTION | Resolved | 2023-08-14 | 2023-12-14 | 201801 |
FETZIMA | 120MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2023-07-21 | 2023-08-16 | 199542 |
RESTASIS MULTIDOSE | 0.05% | EMULSION | Resolved | 2023-06-08 | 2023-07-20 | 194083 |
ACULAR LS | 0.4% | SOLUTION | Resolved | 2023-06-06 | 2023-07-06 | 193833 |
BYSTOLIC | 5MG | TABLET | Resolved | 2023-05-17 | 2024-02-06 | 192664 |
VIIBRYD | 10MG | TABLET | Resolved | 2023-05-15 | 2023-06-09 | 192501 |
SKYRIZI | 90MG | SOLUTION | Actual shortage | 2023-03-30 | 2023-09-02 | 188265 |
BYSTOLIC | 10MG | TABLET | Resolved | 2023-03-22 | 2023-08-04 | 187625 |
RESTASIS MULTIDOSE | 0.05% | EMULSION | Resolved | 2023-02-10 | 2023-03-02 | 184397 |
RESTASIS | 0.05% | EMULSION | Resolved | 2023-01-10 | 2023-01-27 | 180339 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
LUPRON | 5MG | SOLUTION | Discontinued | 2022-01-31 | 2022-08-17 | 153896 |
ALPHAGAN | 0.2% | LIQUID | Reversed | 2021-12-09 | 2023-12-14 | 150885 |
HUMIRA | 40MG | SOLUTION | Discontinued | 2020-06-29 | 2020-11-19 | 119141 |
NORVIR | 80MG | SOLUTION | Discontinued | 2019-02-20 | 2019-04-01 | 76354 |
MODERIBA | 400MG | TABLET | Discontinued | 2017-11-30 | 2018-08-30 | 31316 |
HOLKIRA PAK | 50MG 12.5MG 250MG 75MG | KIT TABLET | Discontinued | 2017-11-30 | 2018-08-30 | 31302 |
MODERIBA | 200MG | TABLET | Discontinued | 2017-11-21 | 2018-08-30 | 29907 |
TECHNIVIE | 12.5MG 75MG 50MG | TABLET | Discontinued | 2017-11-20 | 2018-05-07 | 29839 |
MODERIBA | 600MG | TABLET | Discontinued | 2017-11-20 | 2018-05-07 | 29835 |
Showing 1 to 9 of 9